Search - tctmd.com

Displaying 941 - 960 of 972

Sort: Relevancy | Date

News Daily News

Early Studies Linking Gut Bacteria to Atherosclerosis, Offer Tantalizing Glimpse at New Drug Target

Michael O'Riordan

December 21, 2015

News Daily News

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

Michael O'Riordan

December 13, 2015

News Daily News

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Michael O'Riordan

December 08, 2015

News Conference News AHA 2015

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

Todd Neale

November 08, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

News Industry News

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

July 09, 2015

News Daily News

US Regional Variability Seen in Incidence, Outcomes of In-Hospital Cardiac Arrest

April 03, 2015

News Daily News

Acute Hyperglycemia Worsens Post-AMI Prognosis

October 24, 2014

News Daily News

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

L.A. McKeown

April 29, 2014

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Daily News

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Yael L. Maxwell

August 30, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Daily News

Lean Body Mass Adds New Evidence to ‘Obesity Paradox’ in CAD Patients

L.A. McKeown

September 12, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

Advertisement

Early Studies Linking Gut Bacteria to Atherosclerosis, Offer Tantalizing Glimpse at New Drug Target

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

Novel Antisense Inhibitor Cuts High Triglyceride Levels

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

US Regional Variability Seen in Incidence, Outcomes of In-Hospital Cardiac Arrest

Acute Hyperglycemia Worsens Post-AMI Prognosis

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Remote Postconditioning Reduces AKI in NSTEMI Patients

Lean Body Mass Adds New Evidence to ‘Obesity Paradox’ in CAD Patients

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content